Open Access Alcoholism
Prevention of alcoholism may be attempted by regulating and limiting the sale of alcohol, taxing alcohol to increase its cost, and providing inexpensive treatment.[21] Treatment of alcoholism may take several forms.[9] Due to medical problems that can occur during withdrawal, alcohol
detoxification should be carefully controlled.[9] One common method involves the use of benzodiazepine medications, such as diazepam.[9] These can be either given while admitted to a
health care institution or occasionally while a person remains in the community with close supervision.[9] Mental illness or other addictions may complicate treatment.[22] After detoxification, group therapy or support groups are used to help keep a person from returning to drinking.[8][23] One commonly used form of support is the group Alcoholics Anonymous.[24] The medications acamprosate, disulfiram or naltrexone may also be used to help prevent further drinking.[10]
High Impact List of Articles
-
The place of raltegravir in the clinical management of HIV-1 infection
Ruxandra Calin, Christine Katlama
Review Article: Clinical Practice
-
The place of raltegravir in the clinical management of HIV-1 infection
Ruxandra Calin, Christine Katlama
Review Article: Clinical Practice
-
Identification of meniscus damage biomarker: implications for the future treatment of knee injury
Vanessa Gabrovsky Cuellar, Jason M Cuellar and Gaetano J Scuderi
Editorial: Clinical Practice
-
Identification of meniscus damage biomarker: implications for the future treatment of knee injury
Vanessa Gabrovsky Cuellar, Jason M Cuellar and Gaetano J Scuderi
Editorial: Clinical Practice
-
Efficacy of tocilizumab, a humanized anti-IL-6 receptor antibody, in rheumatoid arthritis
Yoshiyuki Ohsugi
Priority Paper Evaluation: Clinical Practice
-
Efficacy of tocilizumab, a humanized anti-IL-6 receptor antibody, in rheumatoid arthritis
Yoshiyuki Ohsugi
Priority Paper Evaluation: Clinical Practice
-
Preparation of a polymeric reservoir naltrexone delivery device: Effect of PEG content of the PLA membrane on drug release
Rassoul Dinarvand, Shadi H Moghadam, Pantea Sayar, Mahsa Alaee and Fatemeh Atyabi
Research Article: Clinical Practice
-
Preparation of a polymeric reservoir naltrexone delivery device: Effect of PEG content of the PLA membrane on drug release
Rassoul Dinarvand, Shadi H Moghadam, Pantea Sayar, Mahsa Alaee and Fatemeh Atyabi
Research Article: Clinical Practice
-
Bosentan for treatment of pulmonary arterial hypertension (I)
Sabina A Antoniu
Priority Paper Evaluation: Clinical Practice
-
Bosentan for treatment of pulmonary arterial hypertension (I)
Sabina A Antoniu
Priority Paper Evaluation: Clinical Practice
Relevant Topics in Clinical